RESEARCH AND DEVELOPMENT

We develop innovative products through analytical, preclinical and clinical research.

Product
development

We address population health needs through new product development, which represents 10% of our annual sales investment.

Learn More
  • CANIFARMA recognition (2005) In the Technological Research/Innovation category
  • Mexican Council for Science & Technology (COMECYT, by its Spanish acronym) (2008) Award in the Technology category.
  • Mexican Association of Directors of Applied Research and Technological Development (ADIAT, by its Spanish acronym) Award (2009) For its Technological Innovation
  • Tecnos 2009 Award In the category of Technological Products
Learn More

Clinical studies

The main goal for conducting clinical studies is to ensure safety and efficacy in the manufacture and sale of the products in order to meet the highest quality standards Pharmaceuticals Division

Pharmaceutical Products Division
  • Hypertension
  • Metabolic syndrome
  • Anti tuberculosis
  • Vitamins
  • Pain
  • Antiparasitic
  • Asthma preventative and others
Biotechnological Division
  • Ocular diseases.
  • Inflammatory diseases.
  • Neurodegenerative diseases.
  • Autoimmune diseases.
  • Infectious diseases.
  • Diabetes.
Diagnostic Division
  • Detection of HIV antibodies in serum or plasma through the HIV-Instantest.
  • Detection of anti-Trypanosoma cruzi antibodies to diagnose the Chagas disease.
Learn More

Providing global quality of life.

Our infrastructure, technology, processes and products are supported by high quality and safety standards.

We ensure effective treatments in compliance with requirements and good manufacturing practices set in the current regulations.

Product development
We test and manufacture the best drug productse
Clinical studies
Drug products in compliance with the highest quality standards.